Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases

Hepatitis Monthly

Volumn 11, Issue 4, 2011, Pages 269-272

  Ataei, Behrooz ^a   Yazdani, Mohammad Reza ^a   Kalantari, Hamid ^a   Yaran, Majid ^a   Nokhodian, Zary ^a   Javadi, Abbas Ali ^a   Babak, Anahita ^b   Adibi, Peyman ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HEPATITIS D ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; SUPERINFECTION;

EID: 84857851809     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zaki H, Darmstadt GL, Baten A, Ahsan CR, Saha SK. Seroepidemi-ology of hepatitis B and delta virus infections in Bangladesh. J Trop Pediatr. 2003;49(6):371-4.
2. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Lankarani KB. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008;8(4):281-94.
3. Hassanjani-Roshan MR, Taheri H. Frequency of Chronic Active Hepatitis in Asymptomatic HBV Carriers in Babol, Iran. Arch Iranian Med. 2002;5(2):90-100.
4. Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology. 1985;5(2):188-91.
5. Tapalaga D, Forzani B, Hele C, Paravacini O, Ponzetto A, Theil-mann L. Prevalence of the hepatitis delta virus in Rumania. Hepatogastroenterology. 1986;33(6):238-9.
6. Gaeta GB, Strofolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, et al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology. 2000;32(4 Pt 1):824-7.
7. Ivaniushina VA, Ryzhova EV, Grudinin MP, Katorgina LG, Nikon-ova AN, Vinogradova EN, et al. The frequency of antibodies against delta virus in patients with HBs positive hepatitis. Vopr Virusol. 1996;41(4):166-9.
8. Husa P, Linhartova A, Nemecek V, Husova L. Hepatitis D. Acta Virol. 2005;49(4):219-25.
9. Njoh J, Zimmo S. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia. East Afr Med J. 1998;75(6):327-8.
10. de Miguel J, Collazos J, Mayo J, de Goicoechea MJL, Echaniz C, Mendarte U. Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus. Rev Clin Esp. 1994;194(10):897-900.
11. Belshe RB. Textbook of human virology. 2nd ed.: Mosby-Year Book; 1990.
12. Rezvan H, Forouzandeh B, Taroyan S, Fadaiee S, Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection. 1990;18(1):26-8.
13. Karimi A, Amini Safeh AA. Investigation and Comparison of hepatitis D prevalence in dialysis patients and the donors of HB-sAg carrier. Teb va Tazkieh. 2000;36(30):3.
14. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodefciency virus infections in Hamadan province, Iran: a population based study. J trop med hyg. 1993;96(5):277.
15. Roshandel G, Semnani S, Abdolahi N, Besharat S, Keshtkar AA, Joshaqani H, et al. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran. J Microbiol Immunol Infect. 2008;41(3):227-30.
16. Torabi S, Ebrahim-Poor S, Maljaie H, Naqili B. Seroepidemiologic study on hepatitis delta virus among HBsAg positive subjects in Tabriz, Iran. Urmia Med J. 2002;13:290-7.
17. Alavian SM, Asaari SH, Manzouri Jouybari H, Moghani Lan-karani M, Doroudi T, Hajibeygi B, et al. Frequency and risk factors of hepatitis d virus in hepatitis b patients. Govaresh. 2005;10(1):21-6.
18. Hsieh TH, Liu CJ, Chen DS, Chen PJ. Natural course and treatment of hepatitis D virus infection. J Formos Med Assoc. 2006;105(11):869-81.
19. Delic D, Gotic M, Ostric V, Fridman V, Nikolic P, Jemuovic L, et al. Epidemiology of hepatitis D virus (delta) infection in Yugoslavia. Liver. 1993;13(6):302-4.
20. Chen CJ, Tseng SF, Lu CF, Lin HC, You SL, Chen CS, et al. Current se-roepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan. J Med Virol. 1992;38(2):97-101.
21. Munoz Espinosa LE, Ibarra Salas MJ. Prevalence of hepatitis D in a population of Northeast Mexico and its relationship with other viruses. Rev Gastroenterol Mex. 1997;62(4):246-9.
22. Mumtaz K, Hamid SS, Adil S, Afaq A, Islam M, Abid S, et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol. 2005;20(10):1503-7.
23. Sakugawa H, Nakasone H, Shokita H, Kawakami Y, Nakachi N, Adaniya H, et al. Seroepidemiological study on hepatitis delta virus infection in the Irabu Islands, Okinawa, Japan. J Gastroenterol Hepatol. 1997;12(4):299-304.
24. Celen MK, Ayaz C, Hosoglu S, Geyik MF, Ulug M. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey. Saudi Med J. 2006;27(5):617-20.
25. Kalantari HA, Jalali M. A ten-year study of histological variations of liver and laboratory fndings in 100 healthy hepatitis b carriers. J Isfahan Med Sch (IUMS). 2002;20(67):32-3.